The effects of arginine, homoarginine, a-keto-&guanidinovaleric acid and argininic acid (guanidino compounds that were found to be increased in hyperargininemia) were evaluated on responses to y-aminoburtyric acid (GABA) and glycine (Gly) on mouse neurons in primary dissociated cell culture. GABA and Gly were applied iontophoretically and intracellular microelectrode recording techniques were used.
INTRODUCTION
Hyperargininemia is a rare inborn error of metabolism and is characterized by a deficiency of arginase, the last enzyme of the urea cycle, which converts arginine to urea and ornithine. The first clinical and biochemical descriptions date from 1969 and 197d7-39. At present, hyperargininemia has been diagnosed in at least 32 children of 27 kindreds scattered all over the wor1d',3,4,9,'2,13, 20~21~27~28~31~35~36~40~42. The disease is autosomal recessive and a variety of neurological complications have been reported including mental deterioration, progressive spasticity and seizures which are not temporally related to hyperammonemia.
The hyperammonemia is not persistent and is less pronounced than in other urea cycle disorders and even absent in certain hyperargininemia patients. It has been suggested that ammonia is not the sole toxic agent in this disease, but that arginine and/or its metabolites, the guanidino compounds, might contribute to at least some of the neurological complications of this disease. Indeed, several guanidino compounds, some of which were previously shown to be experimental convulsants, were found to consistently accumulate in biological fluids of hyperargininemic patients"*'*. As a consequence of the arginase deficiency, the serum and cerebrospinal fluid (CSF) arginine and homoarginine levels are increased in hyperargininemia. Analytical results indicate that the secondary catabolic pathway of arginine, which is .most activated in this disease, involves transamination with the formation of a-keto-&guanidinovaleric acid. Moreover, the reduction of a-keto-d-guanidinovaleric acid with the formation of argininic acid was also shown to be pronounced (see Fig. 1 ). Activation of this secondary pathway results in increased serum and CSF concentrations of a-ketod-guanidinovaleric acid and argininic acid. Both aketo-6-guanidinovaleric acid and homoarginine were shown experimentally to be convulsant after topical application to the rabbit and rat sensorymotor cortex'6,41. To our knowledge, the epileptogenicity of argininic acid has not been studied. Arginine did not alter the electroencephalogram after application to the sensory-motor cortex in rabbits at a concentration of 0.1 M16.
A reduction in central nervous system GABAergic inhibition has been suggested to be a cause of epi]epsy14319,24J0.
Several convulsants, including bicuculline, picrotoxin, penicillin, d-tubocurarine and pentylenetetrazol, have been shown to be GABA receptor antagonists, blocking the inhibitory action of GABA by interacting with either the 135 GABA or picrotoxin binding sites8p15,23*25,32. Benzodiazepine receptor ligands which were convulsant or proconvulsant, such as the &carbolines, /l-CCM, #KCE and DMCM, and the pyrazoloquinoline, CGS 8216, reduced GABAergic inhibition through an allosteric interaction with the GABA, receptor2,5,8.'1,26,34. Previously, a-keto-d-guanidinovaleric acid was shown to inhibit GABA and Gly responses, probably by blocking their chloride channels'.
In an attempt to determine the mechanisms through which arginine , homoarginine and arginic acid might contribute to development of seizures in hyperargininemia, we evaluated the effects of these guanidino compounds on responses evoked by iontophoretically applied GABA and Gly recorded from spinal cord neurons in cell culture.
METHODS

Primary dissociated cell culture
Spinal cord neuron cultures were prepared from dissected spinal cords and attached dorsal root ganglia from 12-14-day-old fetal mice as described previouslf9. The tissue was minced and then mechanically dissociated by trituration in Ca2+-and M2+-free balanced salt solution to a suspension of single cells and small clumps. The dissociated cells were suspended in culture medium (90% Eagle's minimal essential medium supplemented with 5.5 g/l of glucose and 1.5 g/l of NaHCO,, 5% heat-inactivated horse serum and 5% Nu-Serum II (Collaborative Research Inc.) (325 mOsmo1) and then plated on sterile collagencoated 35 mm dishes. The cultures were maintained in an incubator with an atmosphere of 93% room air and 7% CO, at 35 "C. The bicarbonate/ CO, buffer maintained pH at 7.4. 5-Fluoro- 2'-deoxyuridine was added to the cultures on days 6-8 to suppress the growth of rapidly dividing nonneuronal cells. Medium was changed twice weekly. Cultures were maint~ned for 4-9 weeks before electrophysiological experiments.
Experimental procedures
Solutions. AI1 recordings were made in a Dulbecco's phosphate-buffeted saline (DPBS) after removal of growth medium. The DPBS, with elevated magnesium ion concentration in order to suppress spontaneous activity, contained (in mM): NaCl, 137; Na,HPO,, 8.06; ISCI, 2.68; KH,PO,, 1.47; CaCl,, 1; MgCl,, 10; glucose, 5.6 (pH 7.3-7.4}. Heavy paraffin oil was applied to the surface of the bathing solution to retard evaporation. Solutions of drugs were prepared on the day of the experiment in the following manner: arginine hydrochloride, homoarginine hydrochloride, a-keto-~-guanidinovaleric acid and argininic acid were dissolved in DPBS to form 10 mM solutions. Aliquots were removed and diluted in bathing medium to obtain the applied solutions. For the study of the influence of the guanidino compounds on GABA responses, arginine, homoarg~ine, aketo-&guanidinovaleric acid and argininic acid were all applied at 1 and 10 mM. In addition, aketo-&guanidinovaleric acid and argininic acid were applied at 100pM. The effects of the guanidino compounds on Gly responses were evaluated at a concentration of 10 mM. CGS 9896, a pyrazoloquinoline previously shown to be a pure benzodiazepine receptor antagonist', was dissolved in dimethylsulfoxide to obtain a 10 mM stock solution. Aliquots were removed and diluted in bathing medium to obtain the applied concentration containing less than 0.1% of dimethylsulfoxide.
Experimental apparatus. For experiments, the culture dish containing the bathing solution was placed on a stage with temperature regulated at 34-35 "C. The stage was mounted on a Leitz inverted microscope fitted with phase-contrast optics to facilitate micropipette placement (using Leitz micromanipulators) and to penetrate cells under direct visual control. Intracellular recordings were made from the somata of spinal cord neurons (>20 pm) using glass micropipettes (20-25 MQ) filled with 3 M KCl. Use of an active bridge circuit (Dagan 8100 or W-P Instruments M707) allowed simultaneous recording of membrane potential and injection of current (for steady-state polarization or periodic stimulation) using a single micropipette. The preamplifier output was led to a 6-channel polygraph (Gould 2600s) for continuous recording.
GABA and Gly responses. GABA (0.5 M, pH 3.4) and Gly (0.5 M, pH 3.0) were applied iontophoretically using 500 ms duration rectangular current pulses at 5 s intervals. Iontophoretic pipettes were positioned to within 2 pm of neuronal somata. The use of 3 M KCl-filled micropipettes shifted the chloride equilibrium potential from about -65 mV to about -20 mV. Under these conditions, an increase of chloride conductance resuited in an outward chloride current, giving depolarizing GABA and Gly responses". Responses of about lo-15 mV in amplitude were evoked following membrane hyperpolarization (-70 to -90 mV) to avoid saturation at or near the chloride equilibrium potential. Effects on GABA and Gly responses were accepted only if the responses returned to control amplitude within 5 min of removal of the drug-containing micropipette.
Drug application. The tested guanidino compounds were applied by local superfusion. A blunt-tipped (5-10 ym) pipette filied with the test solution was positioned 15-30 pm from the soma of the cell under study. The open end of the local superfusion pipette was connected to a pressure regulator, set between 0.4 and 0.8 pounds per square inch (psi), by tight-fitting polyethylene tubing. Pressure pulse duration, regulated by a voltage-activated 3-way valve, was 10 s. Under these conditions, local superfusion produced no artifacts, and application of control solution (DPBS alone) was free of significant effects. When studying the effect of co-application of the guanidino compounds and the benzodi~epine receptor antagonist CGS 9896, the drugs were applied through one local superfusion pipette to avoid flow artifacts. As a control, DPBS alone applied by diffusion was without effect in this paradigm. The local superfusion pipettes and recording micropipettes were held by Leitz micromanipulators. To decrease leakage of drugs into bathing medium, the tips of the local superfusion pipettes were kept in the oil phase between drug application trials. They were lowered into the aqueous phase only when drug application was desired.
Drugs. GABA, Gly and the guanidino compounds arginine , homoarginine and argininic acid were purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.) a-keto-&guanidinova-leric acid was synthesized enzymatically'. Structural formulas of the studied guanidino compounds are shown in Fig. 2 . CGS 9896 (2-(4chloro-phenyl)-2,5-dihydropyrazolo-(4,3-C) quinoline3 (3-H)-one) was obtained from Ciba-Geigy Corp. (Summit, NJ, U.S.A.).
Algebraic and statistical methods. At all applied concentrations, mean values and standard deviations were calculated for the obtained amplitudes of the GABA and Gly responses. The responses obtained during local superfusion of the tested drugs were expressed as percentage of the control responses. The statistical significance of differences between GABA and Gly responses with and without drug application was calculated using the 2-tailed Student's t-test; P < 0.05 was considered statistically significant. and 10 mM and a-keto-&guanidinovaleric acid and argininic acid at lOOpM, 1 mM and 10 mM did not alter resting membrane potential or conductance. Application of recording solution (n = 16) did not significantly alter GABA responses (0.1 + 1.7%). Application of CGS 9896 1 PM (n = 11) was free of significant effects on GABA responses (0.23 5 4.36% increase). Arginine, homoarginine, a-keto-&guanidinovaleric acid and argininic acid rapidly and reversibly reduced GABA-responses in a concentration-dependent manner ( Fig. 3 and Table I ). While arginine was devoid of any significant effect on GABA responses at 1 mM, it significantly decreased GABA responses to 49.3 i: 7.02% of control values at 10 mM. Homoarginine, a-keto-Sguanidinovaleric acid and argininic acid, at all applied concentrations, significantly reduced GABA responses. Argininic acid completely inhibited GABA responses at 10 mM. Argininic acid was the most potent drug in inhibiting GABA responses, followed, in decreasing potency, by a-keto-~-guanidinovaleric acid, homoarginine and arginine .
RESULTS
Direct
Direct effects of arginine, homoarginine, a-keto-Sguanidinovaferic acid and argininic acid on Gly responses
Arginine (10 mM) and argininic acid (10 mM) rapidly and reversibly decreased Gly responses (Fig. 4 and Table II were equally effective in decreasing Gly and GABA responses.
Effects of co-application of arginine, homoarginine, a-keto-d-guanidinovaleric acid and argininic acid with CGS 9896 on GABA responses
The effects of arginine (10 mM), homoarginine (10 mM), a-keto-&guanidinovaleric acid (10 mM) and argininic acid (10 mM) alone or in combination with CGS 9896 (1 PM), a benzodiazepine receptor antagonist, were not significantly different (Table III) .
DISCUSSION
We have studied the effects of 4 guanidino compounds that were found to be increased in cerebrospinal fluid of hyperargininemia patients on responses to the iontophoretically applied inhibitory neurotransmitters GABA and Gly on mouse neurons in primary dissociated cell culture. The guanidino compounds were arginine, homoarginine, aketo-&guanidinovaleric acid and argininic acid. Arginine, homoarginine, a-keto-&guanidinova-leric acid and argininic acid inhibited GABA responses on mouse spinal cord neurons in cell culture in a concentration-dependent manner and inhibited Gly responses at a concentration of 10 mM. Argininic acid was the most potent in inhibiting responses to inhibitory amino acids, followed in decreasing potency by a-keto-6-guanidinovaleric acid, homoarginine and arginine. The observed inhibition of GABA responses was not mediated through the benzodiazepine receptor: CGS 9896, a pyrazoloquinoline and benzodiazepine receptor antagonis?, did not antagonize the guanidino compound-induced inhibition of GABA responses. Earlier studies on neurons in culture demonstrated that the inhibitory neurotransmitters GABA and Gly act through different receptors on the membrane surface",29. Moreover, activation of chloride conductance has been demonstrated to underlie the GABA and Gly receptor-coupled events. Since GABA and Gly exert their inhibitory effects by activation of chloride conductance through interaction with different receptors, our observations suggest that arginine, homoarginine, a-keto-&guanidinovaleric acid and argininic acid, shown here not to be benzodiazepine receptor ligands, inhibit inhibitory amino acid-responses by blocking chloride channels.
Although only observed at concentrations higher than those hitherto found in cerebrospinal fluid, the inhibitory effects of arginine, homoarginine, a-keto-~-guanidinovaleric acid and argininic acid on inhibitory neurotransmitter responses might have pathophysiological importance. Indeed, when evaluating the possible neurotoxicity of a given compound, one should take into account the possibility of an increased susceptibility of the diseased subject as well as the possible accumulation of the substance in brain tissue. Moreover, the studied guanidino compounds might have, perhaps in combination with still other toxins, additive effects. Two guanidino compounds found to accumulate in CSF of uremic patient8, guanidine and methylguanidine, had an additive inhibitory effect on responses to the inhibitory neurotransmitters GABA and Gly (DeDeyn and Macdonald, unpublished observations). An additive effect has also been shown for creatinine, creatine, guanidinoacetic acid and guanidine in an experimental paradigm testing in vitro autohemolysis". Earlier reports demonstrated a-keto-&guanidinovaleric acid16 to be more potent than homoarginine4* in inducing seizures in rabbit and rat, respectively.
